Is it possible to prevent contrast-induced nephropathy with dexpanthenol?

Int Urol Nephrol. 2019 Aug;51(8):1387-1394. doi: 10.1007/s11255-019-02194-2. Epub 2019 Jun 11.

Abstract

Purpose: Contrast-induced nephropathy (CIN) is one of the side effects of diagnostic procedures. Oxidative stress plays an important role in CIN's pathophysiology. Dexpanthenol (Dexp) is a substance with antioxidant efficacy. We investigated the likely protective effects of dexpanthenol for CIN.

Methods: Twenty-four Sprague-Dawley rats were divided randomly into four groups of 6 rats; control (group 1), Dexp (group 2), CIN (group 3) and Dexp + CIN (group 4). All rats were restricted of water moderately to facilitate of nephrotoxicity. Dexp was administered into the intraperitoneally at a dose of 500 mg/kg for 5 days in groups 2 and 4. The same amount of saline was applied via intraperitoneally to group 1 and 3. In CIN and Dexp + CIN groups, L-NAME (10 mg/kg), tenoxicam (0.5 mg/kg) and sodium amidotrizoate (10 ml/kg) were administered on the 4th day via the tail vein for CIN. All rats were euthanized on the 6th day and samples for biochemical and pathological evaluations were collected.

Results: When the Dexp + CIN group and the CIN group were compared, it was found to be provide a significant decline at the level of acute tubular injury and necrosis in kidney biopsies by dexp. Furthermore Dexp significantly reduced the serum cystatin C (Cys-C) levels, not serum creatinine. There was no statistically significant difference between the groups in total oxidant and antioxidant levels.

Conclusions: Dexpanthenol did not have significant effect on oxidative stress of acute kidney injury on this rat model. However, it has ameliorated serum Cys-C levels and histopathological findings of CIN.

Keywords: Apoptosis; Cystatin C; Dexpanthenol; Nephrotoxicity; Radiocontrast media.

MeSH terms

  • Animals
  • Antioxidants / therapeutic use*
  • Contrast Media / adverse effects*
  • Kidney Diseases / chemically induced*
  • Kidney Diseases / prevention & control*
  • Male
  • Pantothenic Acid / analogs & derivatives*
  • Pantothenic Acid / therapeutic use
  • Random Allocation
  • Rats, Sprague-Dawley

Substances

  • Antioxidants
  • Contrast Media
  • Pantothenic Acid
  • dexpanthenol